2026-08-20 · 2026-08 / week-3
Singularity Prices a Funding Reset Before the Share-Claim Stack Is Cleared
Singularity Prices a Funding Reset Before the Share-Claim Stack Is Cleared
Summary: Singularity Future Technology Ltd. has a live financing sequence, not a proven operating reset. A July placement issued common stock and warrants, an August tranche issued more common stock while its near-zero warrants await approval, a new $30 million placement requires shareholder approval, and an August 19 offering adds common and pre-funded shares. The latest filed cash and operating bridge is stale, while the filings use inconsistent share-count and split bases.
Status: Conditional common-stock Short Watchlist. This is research, not personalized financial advice or an execution authorization.
Run scope: U.S. market short opportunities only, as instructed. The current-week folder articles/2026-08/week-3/ was scanned first, then the repository was checked by ticker, issuer, financing mechanism, claim state, and prior direction. No prior SGLY article or signal was found.
Opportunity Ranking
| Rank | Idea | Discovery lane | Why it may be best now | Evidence freshness | Catalyst window | Near-term greater-than-5% move case | Asymmetry | Main reason to reject |
|---|---|---|---|---|---|---|---|---|
| 1 | SGLY | U.S. approval-contingent financing and split-basis claim stack | The live tape is volatile and liquid, while the filings show actual issuance, a $30 million approval-contingent placement, near-zero warrants, a pre-funded offering, stale cash, and an unreconciled denominator | August 12 to August 20, 2026 SEC filings; live Nasdaq quote | First settlement, shareholder-meeting notice and vote, first post-event share-count filing | A failed continuation after the high-volume reversal, a financing settlement, or approval that converts potential claims into a visible supply path can move the stock more than 5% | High on paper, but execution remains blocked | Current quote is close to the session low; cash could be higher after later financings; the share-count bases conflict |
| 2 | XELB | U.S. ATM and going-concern cash clock | A $10 million contractual ATM sits beside a $2.971 million registered baby-shelf maximum, $0.399 million cash, $12.092 million debt, and negative operating cash flow | August 13 to August 19 filings | First ATM sale or no-sale disclosure and next cash filing | A small sale or liquidity disclosure can reprice a sub-$1 issuer with a thin tape | Clear cash and capacity tension | The registered cap is much smaller than the headline ATM, the ATM is optional, and trading volume is thin |
| 3 | EXYN | U.S. effective resale registration and cash runway | A fresh supplement registers 3.659 million shares and 189,753 warrants with no issuer proceeds, while August 19 cash was $4.485 million and first-half operating cash use was $7.076 million | August 19 to August 20 filings | First resale, next share-count filing, and CEO transition follow-up | A holder resale or failed rebound can move a recently listed microcap more than 5% | Strong claim and cash mismatch | The stock is near the intraday low, the IPO supplied cash, and customer or strategic evidence can absorb the overhang |
| 4 | ODYS | U.S. priced public offering versus commercial proof | An $11 million offering adds 3.438 million shares plus a 515,625-share option against 16.807 million shares, while first-half revenue was $0.502 million and operating cash use was $8.713 million | August 13 to August 20 filings | August 21 expected closing and next commercial update | A 20% denominator increase can create a greater-than-5% post-closing move | Moderate | The price is near the $3.20 offer, insiders participated, cash was $17.220 million at June 30, and the company reports aerospace and defense deployments |
Selected opportunity: SGLY.
Why this one now: It combines the freshest and most asymmetric state transition: actual issued shares, a proposed 21.520803 million-share placement, a proposed 6.897636 million-share near-zero warrant block, a 600,000-share common/pre-funded offering, and a special-meeting proxy with the meeting date still blank. The market is providing a real-time test through a 40.8 million-share session, but the underlying filing bridge is not yet reconciled.
Why it can move more than 5% soon: The stock is at $3.5701, up 19.80% from the prior close, with a $3.35 intraday low, a $5.20 intraday high, and 40.8 million shares traded in the Nasdaq/Yahoo snapshots. A first settlement, approval date, actual resale, or share-count filing can force a new denominator or cash assumption. The reverse path is a failed high-volume continuation and a return toward the approval-contingent placement reference. Evidence quality is high for the filings and medium-low for the live market structure.
What should surprise a sophisticated reader: The central issue is not that every disclosed share can be shorted today. It is that the filings describe several different securities states, while the market-data provider and the prospectus do not reconcile to one current denominator. The correct short thesis is therefore a dated information sequence, not a claim that the full potential stack is already float.
The Setup
Singularity is currently described in its latest 10-Q as a freight-logistics business. For the nine months ended March 31, 2026, it reported freight-logistics revenue of $859,146, with one customer accounting for 100% of revenue. Net loss was approximately $5.627 million, and net cash used in operating activities was approximately $21.155 million. The same filing showed $13.644 million of cash, $2.097 million of restricted cash, $2.925 million of notes receivable, and $15.344 million of accounts receivable. These are March 31 figures, not a current balance sheet.
The financing sequence is newer than that operating bridge:
- On July 13, the company reported a completed Regulation S placement of 5,263,158 common shares and 15,789,474 warrants for approximately $2.0 million of gross proceeds. The warrants were initially exercisable at $0.418 per share.
- On August 12, the company reported issuing 2,299,212 common shares under an older securities purchase agreement. It also agreed to amend 6,897,636 warrants to a $0.001 exercise price, but the amended warrants require shareholder approval and had not been issued in the filing.
- Also on August 12, the company agreed to sell 21,520,803 common shares at $1.394 for approximately $30 million, subject to shareholder approval.
- The August 19 prospectus supplement offered 340,000 common shares and 260,000 pre-funded warrants for up to $1.8 million gross proceeds at an effective $3.00 common-equivalent price. Its table stated 3,841,289 shares immediately after the offering, a figure that does not reconcile to the May 14 10-Q share count plus the later reported tranches without a verified split-basis bridge.
The market is trading the funding sequence before the current cash, current denominator, approval, settlement, and resale states are fully observable.
The Market Price
The most recent direct Nasdaq snapshot retrieved for this run showed a $3.5701 last sale, $3.57 bid, $3.59 ask, displayed sizes of 213 bid and 80 ask, and 40,776,029.99 shares of volume at 2026-08-20 14:39:22Z, or 10:39 a.m. Eastern. A Yahoo Finance chart snapshot at 2026-08-20 14:38:59Z showed a day high of $5.20 and a day low of $3.35. The quote is regular-session context, but the top of book is not a full depth, venue-quality, or exit-liquidity audit.
| Market input | Observation | What it means |
|---|---|---|
| Last sale | $3.5701 | Current reference price only; not a verified short entry |
| Prior close | $2.98 | The stock was up 19.80% in the Nasdaq snapshot |
| Bid / ask | $3.57 / $3.59 | A narrow displayed spread, but depth beyond the top quote is unknown |
| Intraday range | $3.35 to $5.20 | The last sale was only about 6.6% above the session low, so shorting the current tape is prohibited |
| Session volume | 40.8 million shares | Strong event or momentum activity, not proof of borrowable float or holder resale |
| Provider market-cap snapshot | $19.1 million at 14:18:46Z | Not used for EV or per-share value because it does not reconcile to the filed and post-event claim states |
The provider field implies roughly 5.35 million shares at the live price. That is below the 7,293,492 shares reported on the May 14 10-Q cover page and does not explain the later financing disclosures. The mismatch is a reason to use price-only scenarios, not a reason to invent a fully diluted market cap.
The Positioning
The latest Nasdaq short-interest page available in this run showed 9,067 shares of short interest as of July 31, 2026, with reported average daily volume of 68,285 and one day to cover. That observation is stale relative to the 40.8 million-share current session. It does not support a crowded-short thesis. The current volume is more plausibly event or momentum flow, but that is an inference, not a directly observed holder ledger.
| Positioning input | State | Desk interpretation |
|---|---|---|
| Reported short interest | 9,067 shares as of 2026-07-31 | Stale and low; do not assume short covering is the main driver |
| Current session volume | 40.8 million shares | A large flow event, but the buyer and seller identities are unknown |
| Options chain | Not available in the Nasdaq check | No options expression is permitted |
| Locate, borrow, recall, and borrow cost | Not verified | Common-stock short remains blocked |
| Full order-book depth and exit liquidity | Not verified | Top-of-book data is insufficient for execution |
The current position is therefore 3/5, not 5/5. The filings support the claim-state disagreement. They do not prove that a short can be borrowed, entered, or exited responsibly.
The Claim-State Ledger
| State | Filed amount or price | Cash / approval state | What can and cannot be inferred |
|---|---|---|---|
| May 14 10-Q denominator | 7,293,492 common shares | Filed before the later financing sequence | A dated denominator, not current float |
| July 13 completed Regulation S placement | 5,263,158 shares and 15,789,474 warrants at $0.38 per unit, warrants initially at $0.418 | Approximately $2.0 million gross proceeds reported | Actual issuance is stronger than a shelf, but later split and denominator states still require reconciliation |
| August 12 issued tranche | 2,299,212 common shares | Issuance reported; the amended warrant block was not yet issued | Actual shares are a state transition; new warrant supply remained approval-contingent |
| August 12 proposed placement | 21,520,803 common shares at $1.394 | Approximately $30 million, subject to shareholder approval | Potential supply and potential cash, not current float or unrestricted cash |
| August 12 amended warrants | 6,897,636 shares at $0.001 | Shareholder approval required; not issued in the filing | A near-zero warrant claim, not current shares or a price floor |
| August 19 public and pre-funded offering | 340,000 common shares plus 260,000 pre-funded warrants | Up to $1.8 million gross; prospectus expected delivery on or about August 19 | Settlement, cash receipt, and resale status require a current filing |
| August 17 preliminary proxy | Approval of the 21,520,803 shares, 6,897,636 warrants, and a 1-for-5, 1-for-10, or 1-for-20 reverse split | Special-meeting date was blank in the filed preliminary proxy | A dated vote would make the supply path more observable; a reverse split alone changes display arithmetic |
The simple stress ratios are informative but not current-float claims. The proposed 21.520803 million shares equal approximately 2.95 times the May 14 10-Q denominator. The proposed 6.897636 million warrants equal approximately 0.95 times that denominator. Combined, they equal approximately 3.90 times the dated denominator. Because the later filings use different transaction and split references, these are screening ratios only.
The Gap
Fact: The company has disclosed multiple financing states, including actual issuance and approval-contingent securities.
Fact: The last detailed cash and operating filing predates most of the new financing sequence. It showed less than $1 million of quarterly-scale revenue, one customer representing all reported revenue, and nine-month operating cash use above $21 million.
Fact: The market has produced a 40.8 million-share regular-session tape with a wide intraday range.
Inference: The market is assigning value to access to capital, a proposed capital reset, and possibly the digital-asset narrative faster than it is assigning value to collected freight revenue and a reconciled common denominator.
What the market may be right about: A $30 million financing, if approved and closed, would be real liquidity. A reverse split could support listing compliance and create a fresh display-price narrative. A completed public offering could place cash on the balance sheet. The company has already regained Nasdaq's minimum-bid compliance through the August 7 observation period. Those are legitimate squeeze paths.
Variant perception: The short edge is not “all 28.4 million potential shares are float.” The edge is that approval, settlement, issuance, cash receipt, registration, resale, and split basis are being discussed as one funding reset when they remain separate states. The cheapest tradeable information is the next state transition.
The Catalyst Path
- First post-offering settlement and cash filing. Confirm whether the August 19 common/pre-funded offering closed, how much cash was received net of fees, how many shares were issued, and whether any resale registration or holder sale is visible.
- Special-meeting notice. The preliminary proxy lists approval of the 21.520803 million shares, the 6.897636 million near-zero warrants, and a reverse split, but does not yet provide a meeting date. A dated notice is the next urgency step.
- Shareholder vote and warrant state. Approval would convert the warrant amendment from a proposal into an issuance path. It would not by itself prove exercise or resale.
- Next common-share and cash bridge. Reconcile the post-event common denominator, restricted cash, unrestricted cash, operating burn, debt, judgment or settlement claims, and all actual issuance.
- First documented holder resale or warrant exercise. This is the cleanest proof that potential supply has become tradable supply. Until then, the short remains conditional.
- Next operating disclosure. Test whether freight revenue, customer concentration, collections, and operating cash flow improve together. A financing receipt is not operating proof.
The Payoff Map
The price map is intentionally price-only. The latest balance-sheet date, the provider market-cap field, the current common denominator, the approval state, and the live execution state do not share one auditable timestamp. Enterprise value is not computed.
Top Case for the Short
The proposed placement remains a supply overhang, the public/pre-funded offering settles without an operating inflection, the shareholder process makes the claim stack more visible, and the stock compresses toward $1.40. The $1.394 proposal price is a scenario anchor, not a floor.
Base Case
The company receives some financing, but the 21.520803 million-share placement and near-zero warrants remain unresolved or only partly usable. High event volume fades, operating evidence remains weak, and the stock moves toward $2.40 over the next approval and settlement cycle.
Bottom Case Against the Short
The $30 million placement closes, cash is visibly received, shareholder approval is obtained, the reverse-split proposal creates a new momentum narrative, and no near-term resale appears. A low-float or borrow recall event drives the stock to $6.00 or higher. The bottom case is not a forecast. It is the minimum explicit squeeze test for a thinly reconciled financing story.
Price Target and Probability Map
| Scenario | Probability | Target / level | Return / payoff from $3.5701 | Time horizon | Conditions required | Evidence quality |
|---|---|---|---|---|---|---|
| Top Case for the short | 35% | $1.40 | +60.8% gross short return | One to eight weeks | Proposed supply becomes more observable, operating evidence stays weak, and event flow fades without a durable cash or customer reset | Medium |
| Base Case | 45% | $2.40 | +32.8% gross short return | One to eight weeks | Financing remains partly unresolved, the current tape loses momentum, and no operating inflection appears | Medium-low |
| Bottom Case against the short | 20% | $6.00 | -68.1% gross short return | One to eight weeks | $30 million cash closes, approval and reverse-split momentum dominate, holder resale is absorbed, or borrow is recalled | Medium |
| Invalidation / stop condition | n/a | No numeric stop while entry is null | Keep unarmed | Immediate | Current quote is near the session low or any locate, borrow, recall, depth, venue, volume-quality, or exit-liquidity gate fails | High |
Probability-weighted expected price: $2.77.
Probability-weighted expected short return: approximately +22.4% before borrow cost, recalls, slippage, halts, gaps, and taxes. This is scenario arithmetic, not executable value.
Current market price / level: $3.5701 last sale; $3.57 bid and $3.59 ask.
Timestamp: 2026-08-20 14:39:22Z, regular session.
Primary instrument: Common stock, SGLY. Conditional research only.
Alternative expressions considered: Options were rejected because no usable chain or dealer-positioning data was verified. Leverage, margin, market orders, and any derivative expression are prohibited. A broad crypto or logistics basket would remove the company-specific claim-state catalyst.
Confidence: Medium-low. Primary filing evidence is fresh, but the current denominator, post-offering cash, approval date, actual resale, borrow, and exit-liquidity evidence are incomplete.
What Could Go Wrong
The strongest counterargument is real and simple: management may be assembling enough cash to survive and redirect the company. The proposed $30 million placement would be meaningful against the March operating base if it closes. The July and August financings may already have changed cash materially. The company has regained Nasdaq minimum-bid compliance, and a reverse split can create momentum even when it does not repair economics. The market may be pricing future funding access correctly.
Other failure modes:
- The split-basis mismatch may make the simple stress ratios look larger than the current claim stack.
- The public/pre-funded offering may settle cleanly and be absorbed by buyers, with no forced resale.
- A new digital-asset or logistics customer may generate cash before the next periodic filing.
- A high-volume reversal can continue higher, and a borrow recall can force a short exit before the filing thesis is tested.
- The last short-interest observation is stale. Borrow availability and fee can be materially different from reported short interest.
- The current quote is only about 6.6% above the Yahoo day low. Shorting it now would turn a filing thesis into a momentum gamble.
What Would Prove This Wrong
The short thesis should be removed or materially downgraded if any of the following occurs:
- A current filing reconciles the common denominator on one split basis, shows limited incremental claims, and documents stable cash without a near-term equity need.
- The proposed placement closes with unrestricted cash, the next operating filing shows a credible revenue and collection bridge, and the market absorbs the new shares without a new resale overhang.
- The first post-offering and post-approval filings show holder retention, no meaningful exercise or resale, and a binding customer or strategic contract with collected or contractually funded revenue.
- The stock establishes a higher regular-session range on verified depth and exit liquidity while the claim-state thesis fails to produce new supply.
- Locate, borrow, recall, spread, depth, venue, volume quality, or exit-liquidity gates fail. That blocks execution even if the research thesis remains interesting.
Risk Audit
Strongest counterargument: A $30 million placement, if approved and closed, can buy time and fund a strategic reset. The low revenue base is historical, not necessarily a forecast of the post-financing business.
Most fragile assumption: Approval-contingent securities will become observable, tradable supply within the holding window rather than remaining a proposal while cash improves.
What the market may already know: The financing filings, Nasdaq compliance, reverse-split proposal, and current tape are public. The informational edge is the state separation and reconciliation discipline, not private news.
What could make the trade lose money even if the thesis is directionally right: A gap higher, halt, borrow recall, thin exit market, or an approval headline can overwhelm the modeled price-only return before a resale or cash filing arrives.
Liquidity and execution risks: The displayed $3.57/$3.59 quote is not a complete book. Venue quality, depth, borrow, locate, recall terms, exit liquidity, and short-sale restrictions were not independently verified. The current session is unusually high volume and wide range.
Leverage risks: None permitted. Options, leverage, margin, and market orders are prohibited.
Information reliability risks: The March 31 cash bridge is stale. The May 14 10-Q denominator, July and August issued tranches, the August 19 prospectus table, and provider market capitalization do not reconcile without a verified split-basis bridge.
Invalidation trigger: A current common-share and cash filing that shows the claim stack is not tradable, cash is sufficient, and the operating bridge is improving together. Execution gates failing are also a hard no-trade trigger.
Publish / revise / reject recommendation: Publish as a Conditional Short Watchlist. Do not arm an executable common-stock short.
Best Trade Strategy
Direction: Conditional short bias, research only.
Preferred instrument: Common stock only, if and only if the execution and filing gates clear.
Common-stock stance: entry.price = null. The current quote is reference context, not an entry. Do not short near the session low.
Options stance: No options. The current chain and dealer positioning were not verified.
Take-profit map: Price-only scenario references are $1.40 top case and $2.40 base case. Neither is a floor. Any realized position would require a new risk review after the first actual resale, cash receipt, or share-count filing.
Stop or invalidation: No numeric stop is authorized while the signal is unarmed. Invalidate on a reconciled cash and denominator bridge, binding customer revenue, stable post-event shares, holder retention, or any failed execution gate.
Timeline: First post-offering settlement, the next shareholder-meeting notice, the vote, the first approved-warrant or holder-resale state, and the next cash and operating filing. Review window is one to eight weeks, but the vote date is not yet scheduled.
Execution risks: Near-low quote, gap risk, halt risk, borrow recall, unknown borrow fee, unverified order-book depth, venue and volume quality, and exit liquidity.
Do-not-trade conditions: No verified locate; no borrow or recall terms; quote near an intraday low; spread or full depth unverified; venue or exit liquidity unverified; current denominator or cash bridge not reconciled; approval or settlement headline within the immediate execution window; or any need for options, leverage, margin, or a market order.
Monitoring checklist:
- Confirm settlement and net cash for the August 19 common/pre-funded offering.
- Record the post-event common denominator on one explicit split basis.
- Track the special-meeting date, approval vote, reverse-split ratio, and amended-warrant issuance.
- Verify the first actual exercise, holder resale, or Form 144 notice before treating potential supply as tradable supply.
- Reconcile unrestricted cash, restricted cash, debt, judgment and settlement claims, revenue, customer concentration, and operating cash flow.
- Refresh Nasdaq short interest, locate, borrow, recall, spread, depth, venue, and exit-liquidity evidence before any price-specific expression.
Bottom Line
SGLY is the best current U.S.-short research setup because its financing access is visible before its operating and denominator bridge is. The evidence supports a conditional information sequence, not an immediate short: the current tape is near the session low, the latest short-interest record is stale, and the claim states use incompatible bases. The first settlement, dated shareholder vote, current cash/share filing, and completed resale are the adjudicators. Until they arrive and live borrow and liquidity gates clear, the correct state is watch, entry.price = null, and execution.can_execute = false.
Research Quality Scorecard
| Criterion | Score | Evidence note |
|---|---|---|
| Market disagreement | 5 | Price and volume reflect a funding reset, while the filings separate historical revenue, actual issuance, proposed issuance, approval, and resale states |
| Evidence base | 5 | Fresh SEC filings from August 12 to August 20 plus direct Nasdaq and Yahoo market snapshots |
| Positioning and flows | 3 | Current volume and stale short interest are observable; borrow, recall, options, dealer, fund, and full-depth data are missing |
| Catalyst path | 4 | Settlement, meeting notice, vote, warrant state, resale, and next cash/share filing are monitorable, but the vote date is unscheduled |
| Payoff architecture | 4 | Price-only top, base, and squeeze cases are defined, but the denominator mismatch prevents executable EV |
| Invalidation discipline | 5 | Cash, denominator, customer, holder-retention, and execution invalidation conditions are explicit |
| Differentiated insight | 5 | The thesis focuses on state transitions and split-basis reconciliation rather than treating all disclosed claims as float |
| Client value | 4 | The note identifies the cheapest disconfirming sequence and hard no-trade gates even if no position is taken |
| Total | 35 / 40 | Publishable research quality; remains a Conditional Short Watchlist because execution is fail-closed |
Section 17 Quality Gate
| Gate | Answer | Evidence in this article |
|---|---|---|
| 1. Is the mispricing specific? | Yes | Approval, settlement, resale, split basis, cash, and operating evidence are separated |
| 2. Is there evidence beyond narrative? | Yes | SEC filings, financial statements, Nasdaq quote, short interest, and Yahoo chart are linked |
| 3. Is positioning supported or clearly labelled uncertain? | Yes | Stale short interest and missing borrow, options, flow, depth, and exit data are explicit |
| 4. Is there a catalyst or plausible closing mechanism? | Yes | Settlement, meeting notice, vote, warrant issuance, resale, and cash/share filing |
| 5. Is the downside case described honestly? | Yes | $6.00 squeeze case, cash reset, reverse-split momentum, and recall risk are included |
| 6. Is the strongest counterargument included? | Yes | A real $30 million financing and strategic reset are treated as possible |
| 7. Is the article useful even if the trade is not taken? | Yes | It specifies the cheapest evidence sequence and no-trade gates |
| 8. Are factual claims sourced or marked unverified? | Yes | Primary source URLs and data-gap labels are included |
| 9. Does the article avoid hype? | Yes | No promotional language, certainty claims, or personalized advice |
| 10. Does the headline match the actual evidence? | Yes | The headline says funding reset, not completed operating turnaround |
| 11. Does it explain why this is the best opportunity now? | Yes | The ranking compares four fresh U.S. candidates |
| 12. Does it explain the greater-than-5% path? | Yes | It identifies volume, settlement, approval, resale, and failed-continuation paths |
| 13. Does it identify what should surprise a sophisticated reader? | Yes | The surprise is the unresolved state ladder and split-basis mismatch |
| 14. Do target probabilities add to 100%? | Yes | 35% + 45% + 20% = 100% |
| 15. Is the scorecard in a dedicated section? | Yes | Research Quality Scorecard section included |
| 16. Are reader-facing tables Markdown? | Yes | All tables remain editable Markdown |
| 17. Were optional table images handled correctly? | Yes | No table images were requested or created |
| 18. Is the illustration prompt inline? | Yes | The prompt is at the end of this article and requires the watermark |
| 19. Is Best Trade Strategy complete? | Yes | Direction, instrument, entry, targets, invalidation, timeline, risks, gates, and monitoring are included |
| 20. Are technical signals only timing inputs? | Yes | Intraday range and volume are context; the filing thesis remains independent |
| 21. Was geography handled according to scope? | Yes | The user explicitly restricted this run to U.S. short opportunities |
| 22. Was the Japan lane requirement applicable? | Yes | Not applicable under the explicit U.S.-only scope |
| 23. Was live Substack publishing required? | Yes | Not requested; this run delivers repository article, signal, and process updates |
Sources
| Source | Tier | Date / timestamp | Used for |
|---|---|---|---|
| Singularity March 31, 2026 Form 10-Q | Tier 1 SEC filing | Filed 2026-05-14; period ended 2026-03-31 | Revenue, customer concentration, cash, restricted cash, OCF, loss, liabilities, and dated common denominator |
| Singularity July 13, 2026 Form 8-K | Tier 1 SEC filing | Filed 2026-07-13 | Completed Regulation S shares and warrants |
| Singularity August 12, 2026 Form 8-K for the proposed placement | Tier 1 SEC filing | Filed 2026-08-17; event 2026-08-12 | $30 million proposed placement and approval condition |
| Singularity August 12, 2026 Form 8-K for issued shares and warrant amendment | Tier 1 SEC filing | Filed 2026-08-18; event 2026-08-12 | Issued 2,299,212 shares and unissued near-zero warrants |
| Singularity August 17, 2026 preliminary proxy | Tier 1 SEC filing | Filed 2026-08-17 | Meeting proposals, blank meeting date, warrant approval, and reverse-split alternatives |
| Singularity August 19, 2026 Form 424B5 | Tier 1 SEC filing | Filed 2026-08-19 | 340,000 common shares, 260,000 pre-funded warrants, $1.8 million gross proceeds, and prospectus denominator table |
| Nasdaq SGLY quote snapshot | Tier 2 market data | 2026-08-20 14:39:22Z | Last sale, bid, ask, displayed sizes, timestamp, and volume |
| Yahoo Finance SGLY daily chart | Tier 2 market data | 2026-08-20 14:38:59Z | Intraday high, low, and daily price context |
| Yahoo Finance SGLY quote | Tier 2 market data | 2026-08-20 14:18:46Z | Provider market-cap snapshot and the reconciliation warning |
| Nasdaq SGLY short-interest page | Tier 2 market data | Latest listed settlement 2026-07-31 | Stale short-interest, average-volume, and days-to-cover observation |
| Xcel Brands August 19, 2026 Form 424B5 | Tier 1 SEC filing | Filed 2026-08-19 | Ranked ATM alternative |
| Xcel Brands June 30, 2026 Form 10-Q | Tier 1 SEC filing | Filed 2026-08-13 | Ranked alternative cash, debt, revenue, and operating-cash-flow bridge |
| Nasdaq XELB quote snapshot | Tier 2 market data | 2026-08-20 14:38:08Z | Ranked alternative price and volume |
| Exyn August 20, 2026 Form 424B3 | Tier 1 SEC filing | Filed 2026-08-20 | Ranked resale alternative |
| Exyn June 30, 2026 Form 10-Q/A | Tier 1 SEC filing | Filed 2026-08-20 | Ranked alternative cash, operating-cash-flow, share, and going-concern bridge |
| Nasdaq EXYN quote snapshot | Tier 2 market data | 2026-08-20 14:37:23Z | Ranked alternative price and volume |
| Odysight August 20, 2026 pricing press release filed as Exhibit 99.1 | Tier 1 SEC filing | Filed 2026-08-20 | Ranked priced-offering alternative |
| Odysight June 30, 2026 Form 10-Q | Tier 1 SEC filing | Filed 2026-08-13 | Ranked alternative revenue, cash, operating-cash-flow, and share bridge |
| Nasdaq ODYS quote snapshot | Tier 2 market data | 2026-08-20 14:18:29Z | Ranked alternative price and volume |
AI Illustration Prompt
Create a realistic, high-value, high-end elite, beautiful master editorial illustration for The Mispricing Desk about Singularity Future Technology Ltd. (SGLY): a public company whose share price is moving faster than its cash, denominator, and financing states can be reconciled. Compose a quiet institutional forensic scene with a graphite ledger in the foreground labelled "SGLY $3.5701", "40.8M volume", "$3.35 low", and "$5.20 high". Arrange several transparent filing sheets as separate layers, not one blended stack: a July sheet marked "5.263M issued + 15.789M warrants", an August sheet marked "2.299M issued", a sealed envelope marked "21.520803M proposed at $1.394, approval required", a small pre-funded warrant card marked "340K common + 260K pre-funded", and a proxy calendar with the meeting date left blank. Behind the ledger, show a modest freight-logistics warehouse with one customer door lit, a cash-flow panel labelled "9M revenue $0.859M", "9M OCF -$21.155M", "cash $13.644M, restricted $2.097M, as of Mar 31", and a warning label "denominator basis unresolved". Add a thin split-screen ruler with understated markers reading "issued", "proposed", "approved", "settled", "resold", and "cash received". Use paper white, graphite, deep navy, steel blue, muted amber, and one restrained red execution accent. Mood: forensic, calm, skeptical, expensive, and unresolved, like a Bloomberg Markets or Barron's feature cover. Avoid rockets, crypto coins, generic candlestick charts, money piles, meme-stock imagery, neon finance effects, and promotional AI clichés. Include a subtle but clear semi-transparent watermark or engraved text reading "The Mispricing Desk" integrated into the lower-right corner.